Heart disease rarely begins with chest pain. Or blocked arteries. Or dramatic symptoms that send someone rushing to the hospital. It begins quietly. Invisibly. At the cellular level.
In the presentation Beyond Cholesterol: How CardioZoomer + Cardio Genetics Change the Game, Dr. Giovanni Campanile reframes the way we think about cardiovascular disease. The earliest damage does not occur where traditional tests look. It happens inside the artery walls, years before plaque hardens or symptoms appear.
By the time standard testing raises concern, the process is often well underway.
Before Blockages, There Is Breakdown
At the center of early heart disease is a structure most people have never heard of. The endothelium.
This is a single-cell layer lining every artery in the body. It regulates blood flow. Controls dilation and constriction. Acts as a barrier. And when it functions well, arteries stay flexible and protected.
When it fails, trouble begins. Endothelial dysfunction allows harmful particles to slip beneath the surface. Inflammation rises. Oxidative stress accelerates. Lipids that once floated harmlessly in the bloodstream now lodge themselves in the vessel wall.
This is the first domino. No calcium yet. No blockage. Just cellular injury.
Why Cholesterol Misses the Early Story
You can have normal LDL and HDL levels, yet endothelial damage may still be progressing. As a result, heart disease can appear “out of nowhere” in people who were told their numbers looked fine.
The real issue isn’t cholesterol entering the bloodstream. Instead, it’s cholesterol entering the artery wall. This only happens once the protective lining breaks down. Fortunately, advanced markers can reveal this earlier phase, while traditional panels cannot.
The Cellular Signals That Appear First?
Long before a plaque becomes visible, the body releases biochemical clues. These signals reflect stress, inflammation, and vascular dysfunction.
CardioZoomer identifies many of these early warnings, including:
- Markers of endothelial dysfunction such as ADMA and SDMA
- Oxidative stress indicators tied to cellular damage
- Inflammatory signals that drive plaque instability
- Ceramides linked to metabolic and vascular risk
- Redox imbalance that weakens arterial defenses
These markers don’t diagnose blockages. They reveal vulnerability.
Inflammation Changes Everything
One of the most important shifts in modern cardiology is the recognition that inflammation is not a side effect. It is a driver. Chronic inflammation damages endothelial cells. It disrupts nitric oxide production. It attracts immune cells that worsen arterial injury. Over time, it turns early dysfunction into structural disease.
This explains why lowering inflammation can reduce heart events even when cholesterol levels stay the same. It also explains why lifestyle alone sometimes isn’t enough if deeper inflammatory processes remain unaddressed.
The earliest warning signs are chemical, not mechanical.
The Role of Oxidative Stress?
Oxidative stress acts like rust inside the vascular system. It alters lipids. Injures cells. Exhausts repair mechanisms. When LDL becomes oxidized, immune cells rush in. Macrophages attempt cleanup. Plaque becomes more complex. More dangerous.
None of this requires a blockage to be present.
It only requires time.
Listening Earlier Changes Outcomes
The power of cellular-level testing lies in timing. When dysfunction is identified early, intervention can focus on restoring balance rather than reacting to damage. It allows clinicians to understand why risk exists, not just whether it does. Heart disease does not begin with collapse. It begins with imbalance. At the cellular level, the warning signs are always there. We simply have to know how to listen.
